PODCAST · health
Orthopedics This Week
by RRY Publications, LLC
We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of
Episodes
-
New Bill Streamlines Medical Device Process
Bipartisan bill HR 2474 the Medical Product Review Harmonization Act of 2017 was submitted by California U.S. House of Representatives Mimi Walters and Ami Bera on May 16, 2017. If passed the bill will make certain Class II medical devices quicker and easier to get FDA clearance—including…
more -
Hanging Tough: Lumbar Disc Replacement Over Fusion
Jack Zigler keeps tracking his ProDisc patients, now 12 years post FDA approval. Just as he found at 3 years, 5 years and 7 years post approval, LADR is superior to fusion. And cheaper. Yet, on May 1, 2017 United Healthcare cited no long term data to label LADR "unproven." Such a monumental...
-
Spooks, Phishing and Cyberattacks Cripple Hospitals
Spook technology stolen from U.S. spy agencies was used by hackers in a phishing cyberattack that crippled Britain's National Health Service and computers worldwide. Outdated healthcare computer systems make healthcare systems easy targets. Read about this attack and see what you can do to keep...
-
Systemic Bias in Clinical Research
Orthopedics This Week calls for a change in the economic framework for the clinical study process globally. The current system is undermined by systemic bias, lack of reproducibility and scalability. The causes come from multiple factors, many of which are non-corporate. It is time to address…
more -
The Last Men Standing
Once upon a time lumbar arthroplasty was the most innovative and exciting development in spine surgery. Thirteen years ago the procedure hit a reimbursement wall. That was then, this is now. The resurrection of TOPS is the latest sign that lumbar arthroplasty has a second wind.
-
HCAHPS Report Card: A+ or C-?
Millions of patients have evaluated their hospital, physician and nurse experience by way of the HCAHPS survey. Patients seem happy. But CMS isn't. And poorer hospitals are calling foul. We checked with the expert about all this and read a handful of new studies. Conclusion: HCAHPS is a very…
more -
All Aboard the Opioid Tax BOAT
A bill is pending to amend the Internal Revenue Code's Public Health Service Act (PHSA). The Budgeting for Opioid Addiction Treatment Act (BOAT) potentially places a one penny per milligram excise tax on most opioid prescriptions, with the revenue earmarked for opioid treatment programs.
-
A Cry for Help? FDA Bares Concerns in NEJM
The most senior FDA executives went public with their worries, frustration even, we suspect, impotence regarding the plethora of stem cells therapies in the market last November. And that article, which appeared in the New England Journal of Medicine just keeps growing in influence. Here is what...
-
New MIS Spine Study Group Launch; New Study Targets Cellular RA Triggers; Active Implants Names Ted Davis President, CEO
Kern Singh, M.D. is advancing the science of spine with the establishment of the MISSG. New research suggests that we need to look deeper into RA to treat it. Ted Davis, 25-year veteran of life sciences, takes helm at Active Implants.
-
The Case of Brazil's "Prosthetic Mafia"
A private Brazilian insurance group claims U.S. orthopedic and other implant device makers and the U.S. government allegedly violated the Foreign Corruption Act. In numerous private lawsuits, the group alleges a "Prosthetic Mafia" gorged payers.
-
Galatz v. Crosby: Biceps Long Tendon: Pain Generator Requiring Tenodesis in TSA
OK, everyone agrees tenodesis is the way to go for TSA. But with no prospective, randomized clinical trials regarding the long head of the biceps after total shoulder arthroplasty there remain too many questions. Which, of course, results in a spirited debate between Galatz and Crosby.
-
Flatow v Seitz: Optimal Glenoid Fixation Requires Cement
Excellent debate this week. While both debaters agree that metal backed shoulder implants fail, the battle lines are clearly drawn when it comes to uncemented tantalum versus cemented poly. Evan Flatow and Bill Seitz give us an outstanding debate and review this week with Thomas Thornhill...
-
The $1,000 Infection Tax
In this new era of cost containment in medicine, adding over $1,000 to the cost of a procedure sounds fiscally irresponsible. A group of new studies about post op infection rates provide new insights into this critical issue as contributing commentator, Jay Mabrey, M.D., MBA, CPE explains.
-
New Evidence: Mild Concussions Related to ALS
A new concussion model developed by Gretchen Thomsen, Ph.D., of the Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles and colleagues triggered earlier onset of familial Amyotrophic Lateral Sclerosis symptoms. The researchers hope that the model can be used to develop...
-
12 Leading North American Hand Surgeons
According to their colleagues, these are the leading orthopedic hand surgeons in North America. Whether handling the wrist, elbow, or hand, these exemplary physicians have reached the pinnacle of their profession.
-
Romeo v Sperling: Moderate OA in Patients <50: Best Treated with Arthroscopic Debridement
This is a very challenging problem. Young people with severe shoulder problems. Arthroplasty or arthroscopy? In this debate, the nuances are in full display. This is one of CCJR's best. Congrats to Seth Greenwald for this excellent program.
-
Lewallen v. Hofmann: The Cemented All-Poly Tibia: An Affordable Care Act Solution
All-poly tibia is a very cost effective alternative and, says David Lewallen, M.D., should be part of every knee surgeon's armamentarium. BUT, newer modular designs and metal backed trays give today's surgeon more versatility, counters Aaron Hofmann, M.D. This is an essential debate and a must…
more -
Pain Meds and Hearing Loss in Women; Houston Methodist's New Biomechanics Lab; Implant Corrosion Update
Familiar pain meds are associated with hearing loss in women! Houston Methodist is sporting a new ortho biomechanics lab, complete with state-of-the art motion equipment. And Rush is the only facility in the U.S. with a new technology to tackle implant corrosion.
-
Judge Backs DOJ Effort to Stop Aetna-Humana Merger
Seven months after the DOJ filed a lawsuit to stop the $37B Aetna-Humana merger, along with a complementary Anthem-Cigna merger, a district judge rules in favor of the DOJ—but Aetna promises a quick appeal. What does a potential merger mean for the millions of Medicare Advantage customers who…
more -
Zimmer Biomet Finally Settles for $30.5 Million
A decade-long legal battle between Zimmer Biomet, the Department of Justice (DOJ), and Securities and Exchange Commission (SEC) ended in a grand finale with a $30.5 million settlement. Allegations include violations of the U.S> Foreign Corrupt Practices Act (FCPA) and improprieties in Brazil and...
-
$31 Million Lawsuit: Orthopedic Surgeon Seeks Justice After Attack
Renowned orthopedic surgeon Dr. Jamie Alexandra Dale is seeking justice and $31 million after she was attacked and left for dead by her ex-boyfriend and former NFL player Curtis Jordan. Her permanent injuries have left her unable to continue her surgery practice. Her story is not only…
more -
10 Surprising 2017 Shoulder and Foot/Ankle Market Insights
Which companies will increase shoulder and foot/ankle market share in 2017. In mid-December we received a flashlight into the opaque future of those two dynamic extremity markets. The early Xmas gift came courtesy of top global medical technology analyst, Glenn Novarro. Here is what we learned.
-
Untwisting the Obamacare Rubik's Cube
Orthopedic surgeon Dr. Tom Price is in charge of implementing President-elect Trump's promise to repeal and replace Obamacare. He faces a 2,000 page long law and a Rubik's Cube of rules and regulations. But he is the right guy for the job having led the Republican effort over the last couple of...
-
3D Print This!
It's not a revolution, but it is changing orthopedics. 3D printing produced the fastest new product launch in Stryker Spine's history. It also represented 20% of the winning spine technologies for 2016. Stryker's rousing success with Tritanium has lessons for everyone. Here they are.
-
onner v. Haas: Patella Resurfacing: Rarely if Ever Necessary
This week's Orthopaedic Crossfire® debate tackles the sometimes contentious subject of patella resurfacing. Jess Lonner says it is rarely, if ever, necessary. Steven Haas finds a slew of meta studies that say otherwise. Who wins? You be the judge.
-
NASS Issues Major Spine Stim Coverage Recommendations
NASS new guidance document regarding bone growth stimulators for spine fusion brings clarity to an often confusing gaggle of products and indications. Bottom line, the evidence supports some bone stimulators and not others in spine fusion. Here's the story.
-
Jones v. Berend: The Tourniquetless TKA: Let It Bleed
To tourniquet or to not tourniquet, that is the question. Dickey Jones says "Let it Bleed". Keith Berend fights mightily to defend a near defenseless position. But at the end of the day, the winner, it seems, is tranexamic acid. Get ready to read one of the most unusual CCJR debates yet. Have fun...
-
New Spine Surgeon Survey: 10 Surprising Answers
RBC's excellent spine surgeon survey, now in its eighth year, was released a couple of weeks ago and it provided many insightful, even surprising, results. Which products are spine surgeons most excited about? What do they think is happening with reimbursement? Is their business growing or...
-
The Ten Best New Spine Technologies for 2016
Robots, 3D printing and clever strategies for navigating the spinal anatomy dominated this year's winning technologies. Clearly we are in an environment where risk reduction rules. And so our panel selected impressively clever technologies which make every surgeon even more perfect…and awesome....
-
Five Physicians Join Rush; New Vertebroplasty Study; Need Surgery? Name Your Price!
Midwest Orthopaedics at Rush is welcoming five new physicians! New research from Australia is re-examining an old vertebroplasty debate. ZendyHealth and Kerlan-Jobe have teamed up to offer a "name your price" surgery option.
-
Game Changer for Large Joint Patients and Their Rehab
A new, data driven tool which cuts patient assessment time from weeks to, literally, 30 seconds is the hot new technology for professional athletes. Eventually, maybe sooner, it will be coming to a large joint clinic near you. Maybe your clinic. This innovation feels like a game changer. It...
-
The Use of Stems in Complex Primary TKA: Necessary & Sufficient
To stem or not to stem, that is the question when faced with a specifically complex primary or revision knee arthroplasty because of deformity or instability. New Zealander Kelly Vince gives the pro-stem case while HSS' Thomas Sculco shows himself to be a stem-less kind of guy. Who wins? The...
-
Nam v Lombardi — Patient Specific Instrumentation: Added Cost & Unproven Value
Patient specific instrumentation: added cost with no proven value or an evolving technology to raise outcomes and improve OR efficiencies? This very timely debate pits two great surgeon/scientists against each other and in the process sheds light and understanding on this critical issue.
-
Did Zimmer Biomet Just Pull a 'Soft' Turn With Vanguard?
The hype surrounding Zimmer Biomet's Vanguard ID had us double checking with our surgeon friends. They told us this is actually a particularly interesting innovation in total knee arthroplasty. Apparently, the venerable Vanguard knee is still capable of a few new tricks. Here's what we learned.
-
Will a $95 Million Deal Bring Chemonucleolysis Back?
Is chemonucleolysis for painful lower back disc herniation returning? In the 1980s chymopapain achieved fairly wide spread use as a chemonucleolysis agent. Outcomes were highly technique and patient selection dependent. It eventually left the market. Now two large firms have inked a deal to bring…
more -
With 1.2 Million Medical Marijuana Users, Orthopods in Crosshairs
Medical marijuana is the law in 23 states, 1.2 million marijuana cards have been issued and the two most common reasons for getting a medical marijuana card are back and arthritis pain. How should orthopedists in those states deal with the phenomenon of medical marijuana? We have some answers.
-
The 16 Standout North American Sports Knee Surgeons
In the exam room, OR, or the research lab, these are some of the top sports knee surgeons in North America.
-
JBJS Study: Extended Release Steroid Amplifies Pain Relief
New JBJS study offers an intriguing look at an extended release steroid injection for knee pain. Authors Bodick, Lufkin and Kumar report that extended release triamcinolone acetonide (TCA) prolongs and amplifies pain relief in arthritic knees.
-
Jump in Adverse Events Prompts Action From NSPSS
From the late 1990s to today, the number of annual deaths from preventable medical errors has increased roughly four-fold. What is going on? Former head of patient safety at AAOS tackles this troubling statistic head on and discusses new efforts to stem the rising tide of adverse surgical events…
more -
Gonzalez Della Valle v. Gross: Extensive Acetabular Bone Loss: Impaction Grafting, a Preferred Solution
Acetabular bone loss and impaction grafting, for which patients is it good strategy, which patients is it a 'no-way' strategy and is it overly technique dependent? Alejandro Gonzalez Della Valle and Allan Gross, with Daniel Berry moderating, tackle this important and impactful (pun intended)...
-
Berend v. Dunbar: Outpatient TJA: "Drive-Thru" Surgery
Same day total knee arthroplasty is the siren song of large joint reconstruction. Michael Berend has performed over 2,000 knee arthroplasties with 98% of these folks going home the same day and recommends it strongly. Michael Dunbar points out that these are select patients in a tightly…
more -
Thienpont v. Ranawat—UKA: The Gold Standard for Medial Compartment Disease
Unicompartmental Knee or Total Knee? What's not to like about preserving natural kinematics, lower infection rate and good post op range of motion? But can the patient live with higher revision rates? Dr. Thienpont argues for Uni while Dr. Ranawat takes the counter position. Great and timely…
more -
Gehrke v. Haidukewych: Mega Prosthesis for Distal Femoral Peri-Prosthetic Fx's
OK, it's a distal femoral peri-prosthetic fracture. Do you reach for the locking plates, the screws or the intramedullary nails? Or do you opt for a mega prosthesis? This week's Orthopaedic Crossfire® debate tackles this excellent subject with ENDO-Klinik's Gehrke choosing the big implant and...
-
Yet Another Major U.S. Investment Firm Bets on Spine
Legendary private investment firm Stephens Group, LLC has made the leap into spine. Earlier this year another major private equity firm, Kohlberg & Company also put their considerable resources behind a small spine company. Stephens is investing in CoreLink, a relatively unknown St. Louis based...
-
DOJ Sues to Block Insurance Mega-Mergers
The Big Five private insurance carriers—you know who they are—want to consolidate into the Big Three. The U.S. Department of Justice has sued to block them. The American Medical Association agrees and says that if the DOJ fails, private health insurance in America will be forever changed. For the...
-
Inside DePuy Synthes' Strategic Playbook - Part II
DePuy Synthes' new U.S. President Juan-José Gonzalez sat down with OTW recently and painted a picture of an invigorated DePuy Synthes. It's a vision that wraps the implant in a blanket of services and digitized intelligence. Where's DePuy Synthes heading? Into a most interesting future. Check it...
-
Inside DePuy Synthes' Strategic Playbook - Part I
DePuy Synthes has scale, but can it also navigate a changing and ever more challenging orthopedic environment? New leadership and a series of innovative moves paint a picture of a more nimble and aggressive DePuy Synthes. Here is Part 1 of our series: Inside DePuy Synthes's Strategic Playbook.
-
FTC Slams Invibio's PEEK Implant Business Practices. Alleges Monopolistic Practices
Invibio was the first provider of PEEK to obtain an FDA Master File. The product was a game changer. According to the FTC, the company then tried to create a monopoly by locking up customers with exclusivity contracts. When competitors tried to enter, they were blocked. The FTC filed a lawsuit.…
more -
California's "Spinal Cap" Politicians Plead Guilty
Two former California politicians have pleaded guilty to bribery charges and joined nine others who have pleaded guilty in the massive Worker's Comp criminal billing scheme that cost insurers over $600 million. The scorecard keeps growing. More to come?
-
Haidukewych v. Su: ORIF for Displaced Femoral Neck Fx's in the 50-60 Year Old Patient
Open reduction internal fixation or total hip arthroplasty for younger (50-60 years old) patients with displaced femoral neck fractures? This week's debate pits George Haidukewych against Edwin Su. Who wins? You do…with an outstanding debate.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of
HOSTED BY
RRY Publications, LLC
Loading similar podcasts...